Xianbo Bio

先博生物

Xianbo Bio

Biotech/Healthcare

Xianbo Biotech is a clinical-stage cell therapy biotechnology company. Its off-the-shelf (universal) NK platform features proprietary, innovatively designed CAR constructs, paired with mature and robust CMC capabilities for large-scale universal NK cell manufacturing.

Latest round: Series B (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-08-31